Glecaprevir/pibrentasvir is effective and well tolerated in individuals with hepatitis C
Two large 'real-world' studies conducted in Germany and the USA have confirmed the high rates of sustained virological response (SVR) observed in controlled clinical studies of glecaprevir/pibrentasvir (G/P) involving individuals ...
Apr 12, 2019
0
1